Opportunity
South Carolina Sfaa Sfaa #5400030055
Printing and Assembly of Newborn Screening Forms with FDA-Approved Filter Paper
Posted
August 14, 2026
Respond By
September 22, 2026
Identifier
5400030055
NAICS
323111
The South Carolina Department of Public Health is seeking commercial printing services for multi-layered newborn screening forms used in statewide health programs. - Government Buyer: - South Carolina Department of Public Health, Division of Procurement Services - OEMs and Vendors: - OEMs specified for blood collection filter paper: Whatman (903) and Ahlstrom (226) - Products Requested: - DPH 1327 Newborn Screening Form - Multi-layered, image-transferable form - Serial numbering on three layers - Multiple ink colors - Extensive bar-coding - Attached FDA-approved blood collection filter paper (Whatman 903 or Ahlstrom 226) - Protective fold-over flap with biohazard symbol - Carbonless images - Packaging in specified quantities: 120 packages of 25, 240 packages of 50, 500 packages of 100 (totaling ~65,000 forms annually) - Unique/Notable Requirements: - Printing facility must be FDA-registered for medical device production; proof of registration required - Strict quality control for typesetting, printing, and assembly - Delivery to Public Health Laboratory in Columbia, SC - Forms must comply with USPS biohazard symbol requirements - All-inclusive pricing to cover setup and shipping - Services Requested: - Typesetting, printing, assembly, packaging, and proofing services - Pre-production proofs and optional paper/design samples - Period of Performance: - One-year contract with four option years (up to five years total) - Approximately 65,000 forms required annually
Description
This solicitation is for the commercial printing of multi-layered, image-transferable newborn screening forms for the South Carolina Department of Public Health. The contract is for one year with an option to renew for four additional years, requiring approximately 65,000 forms annually. The forms include multiple ink colors, serial numbering on multiple layers, an attached FDA-approved blood collection filter paper, and a protective fold-over flap with a biohazard symbol. The printing facility must be FDA registered for production of this medical device, and the vendor must provide typesetting, printing, packaging, and proofing services according to specified quality standards.